Clinical Trials Directory

Trials / Completed

CompletedNCT04874662

Nicotinamide (NAM) and Pyridoxine (vitamin B6) on Muscle Regeneration ("Satellite-01 Study").

Efficacy and Safety of a Mix of Nicotinamide (NAM) and Pyridoxine (vitamin B6) on Muscle Regeneration: a Randomized, Double-blind, Placebo-controlled Study ("Satellite-01 Study").

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Assessment of safety and efficacy of NAM/B6 oral administration on the amplification and commitment of satellite cells after a muscle injury

Detailed description

NAM/B6 oral administration after a muscle injury ("Satellite-01 study"): Effect on satellite cells as measured by immunofluorescence (Pax7 and myogenin antibodies to detect amplifying and committed satellite cells, respectively) on sections of muscle biopsies from the stimulated leg (leg 2) by muscle biopsies, comparing the study intervention (NAM/B6) to the control intervention (placebo)

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNAM/B6Single daily dose administration will take place from Day 0 (V1) to Day 8 (V4) around 8 am after an overnight fast from the subsequent evening at 9 pm.

Timeline

Start date
2021-05-03
Primary completion
2022-05-24
Completion
2022-05-24
First posted
2021-05-06
Last updated
2024-10-31

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04874662. Inclusion in this directory is not an endorsement.